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background: Fertility problems are frequently followed by early menopause, and early menopause has been associated with increased
risk of type 2 diabetes (T2D). Thus far, it is unknown whether low fertility is independently associated with future T2D risk.
methods: We assessed the association between measures of low fertility and T2D in the Prospect-European Prospective Investigation
into Cancer and Nutrition (EPIC) cohort of 17357 Dutch women, aged 49–70 years at baseline using Cox proportional hazards models,
adjusted for various confounders. To investigate whether BMI and waist circumference inﬂuence the observed associations, analyses were
additionally adjusted for these variables.
results: At baseline, 332 women had T2D. During a mean follow-up of 9.1+3.6 years, 535 T2D cases occurred. Out of 15707
Prospect-EPIC women who wanted to get pregnant, 1940 consulted a physician for fertility problems and 700 remained childless. No relation
was found between consulting a physician for fertility problems or nulliparity and T2D risk. Of all women who wanted to get pregnant, 3946
(25.1%) had one or more miscarriages, with an average of 1.4 (+0.9) miscarriages and a maximum of 10 miscarriages. Women who had one
or more miscarriage showed the same risk for T2D as women who had no miscarriage. Also, none of the other measures of low fertility
were associated with increased risk for T2D.
conclusions: Generally, measures of low fertility were not independently associated with a risk of T2D in a cohort of 17357
Dutch women.
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Introduction
Compared with all other populations with a modern lifestyle, the
age-adjusted prevalence of type 2 diabetes (T2D) in populations of
European ancestry is relatively low (King et al., 1998; Uitewaal et al.,
2004; Nolan et al., 2011); in the USA, for populations of European,
African, Hispanic and Pima Indian descent, the prevalence of T2D in
both sexes is 7.6, 13, 17 and 50%, respectively (King et al., 1998). It
has been proposed that these differences in T2D susceptibility
between European and non-European populations are the genetic
and evolutionary consequences of geographical differences in the
history of food consumption (Diamond, 2003; Corbett et al., 2009).
The ‘thrifty genotype theory’ hypothesized that the T2D phenotype
gives a survival advantage during periods of famine but is maladaptive
in societies with high food abundance (Neel, 1962). Historical data
show that, starting from about 1600, European societies became
capable of efﬁciently avoiding famine, by redistributing any over-
abundance of grain to areas of food scarcity (Rotberg et al., 1985).
Diamond suggested that as a result, Europeans should have undergone
an epidemic in T2D starting several centuries before the present as a
result of the new reliability of sufﬁcient food supplies, and eliminated
the most T2D-prone genotypes by processes of natural selection
(Diamond, 2003).
Natural selection works through differences in reproductive success
rather than simple differential survival. As fertility is a driving force
behind evolution, infertility could be one of the underlying mechanisms
through which T2D genotype is selected against, especially as T2D is a
late-onset disease and therefore not directly acting on survival.
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underlying causes of the decreased T2D genotype frequencies in Eur-
opeans. However, it is unknown whether T2D is associated with
reproductive problems earlier in life, although there is indirect evi-
dence suggesting that patients with T2D experience reproductive pro-
blems before disease onset. Fertility problems are frequently followed
by early menopause (Kok et al., 2003), and early menopause has been
associated with premenopausal diagnosis of T2D (Dorman et al.,
2001). Obesity, the most important risk factor for T2D, is associated
with reduced fertility. Previously, a U-shaped association between BMI
and relative risk of ovarian infertility was observed in the Nurses’
Health Study II, with increased risk for ovarian infertility for women
with a BMI ,20 and .24 kg/m
2 (Rich-Edwards et al., 2002).
Thus far, it is unknown whether low fertility is indeed associated
with the risk of developing T2D. Therefore, we assessed the associ-
ation between measures of low fertility and T2D risk in the
Prospect-European Prospective Investigation into Cancer and Nutri-
tion (EPIC) cohort comprising 17 357 Dutch women.
Materials and Methods
Subjects
The Prospect-EPIC cohort is one of the two Dutch contributions to EPIC
(Riboli, 1992). It is a prospective cohort study among 17 357 women aged
49–70 years who lived in Utrecht and vicinity and who participated in the
breast cancer-screening programme between 1993 and 1997.
All participants gave their written informed consent and the study
was approved by the Institutional Review Board. The design, sampling
strategies and examination techniques of the cohort have been described
previously (Boker et al., 2001).
Data collection
Baseline measurements
At baseline, all participants ﬁlled out detailed questionnaires on usual diet,
reproductive history, presence of chronic diseases and related potential
risk factors. Women underwent a brief medical examination and a
blood sample was drawn.
Measures of reduced fertility
For each analysis, we used the following variables in an appropriate
subpopulation: (i) subfertility, deﬁned as a positive answer to the question
whether a woman ever consulted a medical doctor for fertility problems,
in all women who reported that they have tried to achieve pregnancy;
(ii) nulliparity, in women who reported that they have tried to achieve
pregnancy; (iii) having only one child, in all parous women; (iv) at least
one miscarriage, in all women who were ever pregnant; (v) time
interval . 5 years between birth of ﬁrst and second child, in women
with at least two live born children and (vi) menstrual cycle irregularity,
in all women reporting on menstrual cycle pattern. The information
on menstrual cycle pattern concerned the period between age 30 and
40 years in which women were not using oral contraceptives. Irregularity
of the menstrual cycle pattern was self-deﬁned.
Potential covariates
Age, BMI, waist circumference, physical activity, socio-economical status,
smoking and alcohol use could potentially inﬂuence both fertility and
susceptibility to T2D. Therefore, we adjusted our analyses for age,
alcohol intake, physical activity, smoking and socio-economic status. We
additionally adjusted for oral contraceptive use as this obviously affects
reproductive outcome and oral contraceptive use might affect sex
steroid hormone levels in women using them, which could inﬂuence
T2D risk. To assess whether BMI and waist circumference inﬂuence the
association between fertility and T2D risk, we adjusted for these measures
in subsequent models.
Body weight was measured to the nearest 0.5 kg, while wearing light
indoor clothing without shoes using a ﬂoor scale (Seca, Atlanta, GA,
USA). Additionally, height, waist circumference and hip circumference
were measured. BMI was expressed as kg/m
2.
Alcohol consumption was assessed by a validated food frequency
questionnaire. Baseline alcohol intake was determined by multiplying
the consumption of each beverage by its ethanol content and was
expressed as g/week. Subsequently, we categorized subjects into four
categories of alcohol consumption: ,0.05 , 0.05–5.5, 5.5–10.5 and
.10.5 g/week.
Duration and types of physical activity during the year preceding study
recruitment were assessed by a set of questions that was used in all
EPIC cohorts. By combining occupational physical activity with time
spent on cycling and sporting in summer and winter, the validated
Cambridge Physical Activity Index (Wareham et al., 2003) was calculated
(Beulens et al., 2010a,b). Based on this index, participants were assigned
to one of four categories: inactive, moderately inactive, moderately
active and active.
Smoking behaviour was categorized as no, former or current smokers.
To deﬁne socio-economic status, the highest attained level of education
of the participants was used and classiﬁed into three categories: low
(primary education up to completing intermediate vocational education),
middle (up to higher secondary education) and high (those with higher
vocational education and university).
The number of years of oral contraception use was self-reported,
and participants were assigned to one of four groups: never, 1–4, 4–10
and .10 years.
Missing value analyses
Missing values for BMI, waist circumference, alcohol intake, smoking,
gestational diabetes, socio-economic status, years of oral contraceptives
use, number of miscarriages and age of menarche were imputed using mul-
tiple imputation (van der Heijden et al., 2006) and repeated ﬁve times to
account for uncertainties in imputed data. None of the variables had .5%
missing values; the percentage of missing values ranged from 0.1% for BMI
to 2.9% for years of oral contraceptives use.
Morbidity and mortality follow-up
Occurrence of prevalent T2D was obtained via self-report in the base-
line questionnaire and through linkage to the Dutch register of hospital
discharge diagnoses (HDD) for the period before enrolment. Information
on incident T2D was obtained via self-report in two follow-up question-
naires sent to the participants within intervals of 3–5 years, linkage to
the Dutch register of HDD and a mailed urinary glucose strip test
(part of the cohort) (Sluijs et al., 2010). Potential prevalent and incident
cases of T2D were veriﬁed against information from the participants’
general practitioner or pharmacist through mailed questionnaires. T2D
was deﬁned as being present when the general practitioner or pharma-
cist conﬁrmed the diagnosis. Information on vital status was obtained
through linkage with the municipal administration registries (Herings
et al., 1992). Causes of death were obtained from the Dutch Central
Bureau of Statistics, coded according to the International Classiﬁcation
of Diseases, Tenth Revision, Clinical Modiﬁcation (ICD-10). For our
analyses, T2D was the end-point of interest and follow up ended at
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on 1 January 2006.
Data analysis
Population characteristics were described using mean and SD (for nor-
mally distributed variables) and number and frequency (for categorical
variables).
The person-time for each woman was calculated from birth to the
month of diagnosis of the end-point (T2D), the month of death from
other causes or the end of follow-up (1 January 2006). In prospective
cohort studies, the person-time is usually calculated from baseline, there-
fore only including incident T2D cases. As our variables for measures of
low fertility were established long before T2D onset in cases, we chose
to calculate person-time from birth. This allowed us to include an extra
332 prevalent T2D cases for analyses, which would otherwise be
excluded. Person-time from birth has been used in another study where
a variable (age of menarche) was estimated before baseline (Lakshman
et al., 2008). We additionally studied the association of low fertility and
T2D risk with person-time calculated from baseline, to explore the
effect of using a person-time from baseline versus from birth. Two
approaches were used to assess the validity of the proportional hazards
assumption. First, the assumption was assessed by log-minus-log-survival
function and found to hold. Second, to conﬁrm the assumption of propor-
tionality, time-dependent covariate analysis was used. The time-dependent
covariates were not statistically signiﬁcant for all but one covariate,
suggesting that the proportional hazards assumption is reasonable.
The time-dependent alcohol use covariate was statistically signiﬁcant
(P ¼ 0.009), however, removing alcohol use from the model did not
change our results.
Hazard ratios (HRs) and 95% conﬁdence intervals (CIs) for risk on T2D
were estimated using Cox regression analysis. We used a stepwise
approach to adjust for potential confounders and study the role of the
potential intermediate factors, BMI and waist circumference, using ﬁve
multivariate models: model 1, including age at baseline (for analysis using
person-time calculated from baseline); model 2, including potential con-
founders age, alcohol intake, physical activity, smoking, socio-economic
status and oral contraceptives use; model 3, including all confounders
from model 2 and BMI; model 4, including all confounders from model
2 and waist circumference.
All statistical analyses were performed using the Statistical Package for
the Social Sciences (version 19). Statistical signiﬁcance was set at P , 0.05.
Results
Table I shows the baseline characteristics of the population included in
this study. The study had a mean follow-up of 9.1+3.6 years and
comprised 157964 person-years. Calculating follow-up time from
birth resulted in a mean follow-up of 66.8+6.7 years with a corre-
sponding 1160428 person-years. The mean age of the study group
at baseline was 57.1+6.0 years. In total, the study contained 867
veriﬁed T2D patients; 332 prevalent and 535 incident cases.
Table II shows the relation between different measures of low
fertility and T2D risk. Unadjusted and adjusted HRs were all small,
with 95% CIs often including 1.00 or barely missing 1.00. When
fully adjusted, there was no association between any of the measures
of low fertility and T2D risk.
Out of the 15707 women who wanted to get pregnant, 1940
(12.4%) consulted a physician for fertility problems and 133 women
(0.8%) did not report whether or not they had a consultation. Con-
sulting a physician for fertility problems was not associated with risk
of T2D. Of these 15 707 women, 700 (4.5%) remained childless.
No relation was found between nulliparity and T2D risk. Furthermore,
3946 (25.1%) women in this group had one or more miscarriage(s),
with an average of 1.4 (+0.9) miscarriages and a maximum of 10 mis-
carriages. Women who had one or more miscarriage showed no
different risk for T2D compared with women who did not have a
miscarriage.
Of the 15 007 women who did have children, 1470 (9.8%) women
were uniparous. Compared with women with two or more children,
women with only one child had a decreased risk for T2D, with a multi-
variate adjusted HR of 0.78 (95% CI 0.60–1.02), although not signiﬁ-
cant. The average time interval between the ﬁrst and second child was
32.7 (+20.4) months. Women with a time interval of 5 years or more
between their ﬁrst and second child had an increased risk for T2D,
with an unadjusted HR of 1.27 (95% CI 1.00–1.62) compared with
women with two or more children. However, after multivariate adjust-
ment, this association was no longer signiﬁcant, with a multivariate
adjusted HR of 1.11 (95% CI 0.87–1.41).
A total of 17357 women reported on regularity of natural men-
struation between the age of 30 and 40 years, of whom 1947
(11.4%) reported having an irregular menstrual cycle. Compared
with women with regular cycle length, women with irregular menstrual
cycles had an increased risk for T2D, with an unadjusted HR of 1.27
(95% CI 1.04–1.54). However, after adjustment for multiple covari-
ates, the association between irregular menstrual cycles and increased
T2D risk was no longer signiﬁcant.
The results for the analyses using only incident cases were very
similar to the results including both incident and prevalent cases
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Table I Baseline characteristics of 17357 Dutch
women from the Prospect-EPIC cohort.
Mean + + + + + SD
Follow-up time from birth (year) 66.9 + 6.7
Age at intake (year) 57.1 + 6.0
BMI (kg/m
2) 26.0 + 4.10
Waist circumference (cm) 83.8 + 10.2
Alcohol intake (g/week) 9.1 + 12.6
Oral contraceptive pill use (year) 5.4 + 6.8
Live born children 2.4 + 1.5
Smoking, n (%)
Current smoker 3790 (21.8)
Former smoker 6073 (35.0)
Non-smoker 7494 (43.2)
Physical activity, n (%)
Inactive 1301 (7.5)
Moderate inactive 4612 (26.6)
Moderate active 4437 (25.6)
Active 7007 (40.4)
Educational level, n (%)
Low 13311 (76.7)
Medium 1249 (7.2)
High 2270 (13.1)
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outcome in Cox regression will be estimated on the risk set at the
ﬁrst and subsequent events. The reproductive events and the T2D
outcome did not overlap in most cases, hence not changing the risk
set. Therefore, we decided to present the results using both incident
and prevalent cases.
Discussion
In this large cohort of 17 357 women, measures of low fertility were
not associated with the risk of developing T2D. Therefore, we
could ﬁnd no evidence to support our hypothesis that reduced fertility
is one of the underlying causes of the decreased T2D genotype fre-
quencies in Europeans. To our knowledge, this is the ﬁrst study to
investigate the association between various measures of low fertility
and future T2D risk in a prospective cohort. Our study was
powered to show an association of clinical relevance between
measures of low fertility and T2D, as we had 80% power to detect
a HR of 1.4 for determinant variables with a 10% prevalence, when
including both prevalent and incidence cases.
Before discussing the data, some strengths and limitations need to
be highlighted. The main advantages of this study are its prospective
nature, the long follow-up time and the large sample size. Further-
more, the women were extensively questioned on their reproductive
history and the participants’ general practitioner or pharmacist vali-
dated cases of T2D.
Prospect-EPIC is a prospective cohort study among women who
participated in the breast cancer-screening programme between
1993 and 1997. In the Netherlands, all women aged 50–69 years
are offered a free biennial breast cancer screen examination and the
participation rate is high. Between 1990 and 1995, the overall attend-
ance rate of females in the Netherlands for breast cancer screening
was 77.5% (Fracheboud et al., 1998). Establishing whether the
Prospect-EPIC cohort is representative of the general European
female population is difﬁcult. It is known that volunteers for epidemiol-
ogy studies are, in general, better educated and use health services
less often compared with non-volunteers. However, using a restricted
source population for a cohort study will produce only relatively weak
bias in estimates of the exposure-disease associations (Pizzi et al.,
2011). Also, many baseline characteristics in Prospect-EPIC are
similar to other European cohorts (Boker et al., 2001). We therefore
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Table II Hazard ratios (HR) for T2D by various
measures of low fertility in Prospect-EPIC women with
age as follow-up time.
HR HR (95% CI)
Ever a consult for sub- or infertility No Yes
Subjects (n) 13634 1940
T2D cases (%) 701 (5.1%) 83 (4.3%)
Model 1
a: unadjusted 1 0.88 (0.70–1.11)
Model 2
b: multiple confounders 1 0.97 (0.77–1.22)
Model 3
c: model 2 + BMI 1 1.06 (0.85–1.34)
Model 4
d: model 2 + WC 1 1.05 (0.84–1.32)
Nulliparity No Yes
Subjects (n) 15007 700
T2D cases (%) 762 (5.1%) 31 (4.4%)
Model 1
a: unadjusted 1 0.88 (0.62–1.26)
Model 2
b: multiple confounders 1 0.99 (0.69–1.43)
Model 3
c: model 2 + BMI 1 1.04 (0.72–1.49)
Model 4
d: model 2 + WC 1 1.06 (0.74–1.52)
Uniparity No Yes
Subjects (n) 13537 1470
T2D cases (%) 702 (5.2%) 60 (4.1%)
Model 1
a: unadjusted 1 0.82 (0.63–1.07)
Model 2
b: multiple confounders 1 0.78 (0.60–1.02)
Model 3
c: model 2 + BMI 1 0.84 (0.64–1.09)
Model 4
d: model 2 + WC 1 0.82 (0.63–1.08)
Ever a miscarriage No Yes
Subjects (n) 11761 3946
T2D cases (%) 569 (4.8%) 224 (5.7%)
Model 1
a: unadjusted 1 1.11 (0.96–1.30)
Model 2
b: multiple confounders 1 1.11 (0.95–1.29)
Model 3
c: model 2 + BMI 1 1.05 (0.90–1.22)
Model 4
d: model 2 + WC 1 1.00 (0.86–1.17)
Interval ﬁrst and second child . 5 years No Yes
Subjects (n) 12322 1078
T2D cases (%) 623 (5.1%) 73 (6.8%)
Model 1
a: unadjusted 1 1.27 (1.00–1.62)
Model 2
b: multiple confounders 1 1.11 (0.87–1.41)
Model 3
c: model 2 + BMI 1 1.08 (0.84–1.37)
Model 4
d: model 2 + WC 1 1.05 (0.82–1.34)
Irregular menstrual cycle No Yes
Subjects (n) 15410 1947
T2D cases (%) 750 (4.9%) 117 (6%)
Model 1
a: unadjusted 1 1.27 (1.04–1.54)
Model 2
b: multiple confounders 1 1.06 (0.83–1.36)
Model 3
c: model 2 + BMI 1 1.09 (0.86–1.40)
Continued
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Table II Continued
HR HR (95% CI)
Model 4
d: model 2 + WC 1 1.08 (0.84–1.38)
Women with a time interval of 5 years or more between their ﬁrst and second child
had an increased risk for T2D compared with women with two or more children.
However, after multivariate adjustment, this association was no longer signiﬁcant.
Compared with women with regular cycle length, women with irregular menstrual
cycles had an increased risk for T2D. However, after adjustment for multiple
covariates, the association between irregular menstrual cycles and increased T2D
risk was no longer signiﬁcant.
CI, conﬁdence interval.
aModel 1 ¼ Unadjusted.
bModel 2 ¼ Adjusted for smoking (never, past and current), alcohol intake (,0.05,
0.05–5.5, 5.5–10.5 and .10.5 g/w), socio-economic status (low, middle and high),
oral contraceptive pill years (never, 1–4, 4–10 and .10 years) and physical activity
(inactive, moderate inactive, moderate active and active).
cModel 3 ¼ Model 2 plus BMI (continuous).
dModel 4 ¼ Model 2 plus waist circumference (WC; continuous).
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women.
The variables we used in this study as measures of low fertility have
been used in previous studies as reproductive characters that reﬂect
low fertility (Cramer et al., 1995; Hardy and Kuh, 1999; Kok et al.,
2003). Associations between early age at menopause and a higher fre-
quency of all characteristics that we use in this study, reﬂecting low fer-
tility, were reported previously (Kok et al., 2003).
Although the mean age of participants at baseline was substantially
older than age during the investigated reproduction time, most
measures of low fertility are reﬂecting the current family situation of
women. As this is very stable over time, it will make recall errors
very unlikely, when women are asked to answer questions on this
topic. A previous study in women on the accuracy of recall of
spontaneous abortion showed that 75% of recorded abortions were
recalled (Wilcox and Horney, 1984). Gestational age at time of
abortion was the major determinant of recall, with early abortions
remembered less often, while time since abortion affected the recall
to a lesser extent. Recall of menstrual cycle length is probably the
least reliable of all measures of low fertility used in this study
(Bean et al., 1979).
The variables ‘having consulted a physician for fertility problems’,
‘nulliparity’, ‘uniparity’ and ‘a long time interval between the birth of
the ﬁrst and the second child’ could also have been caused by male
infertility. However, the associations between measures of low fertility
and T2D risk did not change when we excluded women with sub- or
infertile partners (data available on request). Although some misclassi-
ﬁcation of the fertility status of the women cannot be excluded, this is
unlikely to have an effect on the results, since misclassiﬁcation of low
fertile or infertile women occurred independently of T2D.
The variable ‘time interval between birth of ﬁrst and second child’ is
a substitute for time to pregnancy, which is widely used to estimate
the degree of low fertility (Greenhall and Vessey, 1990). In this
study, we were unable to directly determine time to pregnancy in
our cohort, and instead used the interval between ﬁrst and second
child as we expect that this time is, for the most part, unintentional
waiting time. However, this subfertility is most likely of relatively
minor magnitude because all of these women were able to conceive
at least twice. It should also be mentioned that while the inter-
pregnancy interval may be a marker of low fertility, it could also be
a marker of high fertility in a subgroup, as it could represent accidental
pregnancies in women who were satisﬁed with having one child.
In previous studies long or highly irregular menstrual cycles have
been associated with insulin resistance, higher glucose levels and
increased risk of T2D (Weiss et al., 1994; Roumain et al., 1998;
Gast et al., 2010). We previously reported that, compared with
women with a regular cycle length of 27–29 days, women with irre-
gular menstrual cycles tended to be (non-signiﬁcant) at increased
risk for T2D, and had a signiﬁcantly increased risk of coronary heart
disease (Gast et al., 2010). In the present study, we showed that
the association with T2D slightly strengthened after adjusting for
both BMI and waist circumference, separately. However, the nature
of any link between irregular menstrual cycles and T2D remains
unknown. In women with irregular menstrual cycles neither the
association with T2D nor the association with coronary heart
disease could be explained by metabolic risk factors or altered
hormone levels (Gast et al., 2010).
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Table III Hazard ratios for T2D by various measures of
low fertility in Prospect-EPIC women with person-time
from baseline.
HR HR (95% CI)
Ever a consult for sub- or infertility No Yes
Subjects (n) 13365 1908
T2D cases (%) 432 (3.2) 51 (2.7)
Model 1
a: age 1 0.88 (0.67–1.16)
Model 2
b: multiple confounders 1 0.95 (0.71–1.25)
Model 3
c: model 2 + BMI 1 1.04 (0.79–1.38)
Model 4
d: model 2 + WC 1 1.01 (0.77–1.34)
Nulliparity No Yes
Subjects (n) 14717 683
T2D cases (%) 472 (3.2%) 14 (2%)
Model 1
a: age 1 0.72 (0.44–1.17)
Model 2
b: multiple confounders 1 0.80 (0.49–1.30)
Model 3
c: model 2 + BMI 1 0.86 (0.53–1.39)
Model 4
d: model 2 + WC 1 0.87 (0.53–1.41)
Uniparity No Yes
Subjects (n) 13265 1452
T2D cases (%) 430 (3.2%) 42 (2.9%)
Model 1
a: age 1 0.90 (0.66–1.23)
Model 2
b: multiple confounders 1 0.84 (0.61–1.15)
Model 3
c: model 2 + BMI 1 0.90 (0.66–1.24)
Model 4
d: model 2 + WC 1 0.89 (0.65–1.22)
Ever a miscarriage No Yes
Subjects (n) 11537 3863
T2D cases (%) 345 (3.0%) 141 (3.7%)
Model 1
a: age 1 1.17 (0.97–1.42)
Model 2
b: multiple confounders 1 1.18 (0.98–1.43)
Model 3
c: model 2 + BMI 1 1.13 (0.94–1.37)
Model 4
d: model 2 + WC 1 1.09 (0.90–1.32)
Interval ﬁrst and second child . 5 years No Yes
Subjects (n) 12083 1045
T2D cases (%) 385 (3.2%) 40 (3.8%)
Model 1
a: age 1 1.19 (0.88–1.62)
Model 2
b: multiple confounders 1 1.05 (0.77–1.44)
Model 3
c: model 2 + BMI 1 1.02 (0.75–1.39)
Model 4
d: model 2 + WC 1 0.99 (0.72–1.34)
Irregular menstrual cycle No Yes
Subjects (n) 15125 1900
T2D cases (%) 465 (3.1%) 70 (3.7%)
Model 1
a: age 1 1.18 (0.92–1.51)
Model 2
b: multiple confounders 1 1.09 (0.85–1.40)
Model 3
c: model 2 + BMI 1 1.14 (0.89–1.46)
Model 4
d: model 2 + WC 1 1.11 (0.86–1.42)
The results for the analyses using only incident cases (Table III) were very similar to
the results including both incident and prevalent cases (Table II).
aModel 1 ¼ Adjusted for age at baseline (continuous).
bModel 2 ¼ Adjusted for age at baseline (continuous), smoking (never, past and
current), alcohol intake (,0.05, 0.05–5.5, 5.5–10.5 and .10.5 g/w),
socio-economic status (low, middle and high), oral contraceptive pill years (never,
1–4 , 4–10 and .10 years) and physical activity (inactive, moderate inactive,
moderate active and active).
cModel 3 ¼ Model 2 plus BMI (continuous).
dModel 4 ¼ Model 2 plus WC (WC; continuous).
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age of menopause was known were diagnosed after menopause. As
the developing epidemic of obesity at a younger age will result in a sub-
stantial reduction in the age of onset of T2D, which is already emer-
ging in women of childbearing age, it is important to further investigate
the association between the reduced fertility and premenopausal T2D.
Previous studies provide some evidence for the connection between
infertility and premenopausal T2D. First of all, one common cause
of low fertility, namely polycystic ovary syndrome (PCOS), is already
known to be associated with impaired glucose tolerance and T2D in
adolescent girls and premenopausal women (Legro et al., 1999;
Moran et al., 2010). PCOS is a heritable form of ovarian infertility
that clinically affects 5–10% of women of reproductive age and is
characterized by a long history of chronic anovulation in association
with insulin resistance and androgen excess (Azziz et al., 2005, Rotter-
dam ESHRE/ASRM, 2004). Second, reproductive abnormalities are
often part of the metabolic syndrome when it occurs in premenopau-
sal women (Sam and Dunaif, 2003). Metabolic syndrome is recognized
as a major risk factor for T2D (Reusch, 2002). Third, pregnancy losses,
predominantly through stillbirth, are high in women with type 1 dia-
betes and T2D (Macintosh et al., 2006). However, it is unknown
whether T2D-associated phenotypes cause low fertility or whether
low fertility are markers for unknown factors increasing T2D risk in
menopausal women. As our data show that low fertility does not
predict subsequent development of T2D, it is tempting to speculate
that premenopausal T2D is causal for low fertility, rather than the
other way around. Unfortunately, in this Prospect-EPIC study we
were not able to study the association between reduced fertility and
premenopausal T2D risk, owing to the low number of premenopausal
T2D cases.
Our data show that general measures of low fertility are not associ-
ated with T2D later in life. As previous studies provide some evidence
for a connection between low fertility and premenopausal T2D, it is
tempting to speculate that premenopausal T2D is causal for
reduced fertility rather than the other way around. Therefore, the
association between low fertility and risk of premenopausal T2D
should be further studied, as alongside the developing epidemic of
obesity there is a substantial reduction in the age of onset of T2D
and its emergence in women of childbearing age.
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